4.4 Article

Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants

Journal

JOURNAL OF MOLECULAR NEUROSCIENCE
Volume 48, Issue 1, Pages 245-247

Publisher

SPRINGERNATURE
DOI: 10.1007/s12031-012-9820-7

Keywords

Parkinson; SNCA; rs356219; LRRK2; age-at-onset

Funding

  1. Michael J. Fox Foundation [PI041639]
  2. Instituto Carlos III
  3. Spanish Ministry of Science and Innovation [SAF2006-10126, SAF2010-22329-C02-01]
  4. Fundacio La Marato de TV3 [061131]
  5. UTE project FIMA, Spain
  6. CIBERNED post-MIR grant
  7. IDIBAPS

Ask authors/readers for more resources

Mutations in the leucine-rich repeat kinase 2 (LRRK2) and alpha-synuclein (SNCA) genes are known genetic causes of Parkinson's disease (PD). Recently, a genetic variant in SNCA has been associated with a lower age at onset in idiopathic PD (IPD). We genotyped the SNCA polymorphism rs356219 in 84 LRRK2-associated PD patients carrying the G2019S mutation. We found that a SNCA genetic variant is associated with an earlier age at onset in LRRK2-associated PD. Our results support the notion that SNCA variants can modify the pathogenic effect of LRRK2 mutations as described previously for IPD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available